Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
BTG Commences Phase IIa Study of Multiple Sclerosis
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Centocor briefing document for Ustekinumab, submitted to FDA
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
[Infections and fingolimod].
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.

Pages